[{"Assets_0_Q1_USD":357138000.0,"EarningsPerShareBasic_1_Q1_USD":0.1,"EarningsPerShareDiluted_1_Q1_USD":0.1,"NetCashProvidedByUsedInOperatingActivitiesConverted_1_Q1_USD":6529000.0,"NetIncomeLossConverted_1_Q1_USD":1141000.0,"RevenuesConverted_1_Q1_USD":36628000.0,"StockholdersEquity_0_Q1_USD":172212000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":11653000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":11527000.0,"Ticker":"ANIP","CIK":"1023024","name":"ANI PHARMACEUTICALS INC","OfficialName":"ANI Pharmaceuticals Inc.","form":"10-Q","period":"20170331","fy":"2017.0","fp":"Q1","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"569805985.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Biological Products (No Diagnostic Substances)","Market":"NASDAQ","SP500":"nan","filed":"20170504"}]